3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
27
Phase NA
16
Phase 4
16
Phase 3
9
Phase EARLY_PHASE1
4
Phase 2/3
4
Phase 1/2
2
Phase 1
2
Status
Completed
22
Terminated
6
Recruiting
5
Active not recruiting
5
Withdrawn
4
Unknown
2
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
1
Ketosis
1
Insulin Resistance
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Cyclophosphamide
51
fludarabine
38
Injections
32
Gemcitabine
25
Paclitaxel
24
Cisplatin
22
Radiotherapy
19
toripalimab
18
pembrolizumab
18
Carboplatin
17
Capecitabine
17
Fluorouracil
15
Oxaliplatin
14
Nivolumab
14
Docetaxel
12
camrelizumab
11
apatinib
11
Temozolomide
11
Immunotherapy, Adoptive
11
Cetuximab
11
Bevacizumab
10
Irinotecan
9
Drug Therapy
9
sintilimab
8
Etoposide
8
aldesleukin
7
Taxes
7
Rituximab
7
Radiosurgery
7
Peripheral Blood Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Unknown
×
Metformin
×
Clear all
NCT02244567
2021-02-02
U-C OC IN PCOS
Beni-Suef University
Phase 1
Unknown
100 enrolled
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled